Science Explorer Back to mapMap
Discussion
Company · Sunnyvale · United States

Olympia Diagnostics (United States)

olympiadiagnostics.comROR OpenAlex
Research works
5
◆ 0% vs 2018-21
Citations
77
14.1 per fractional work
Top-10% rate
3.2%
all institutions 10.0%
Open access
33%
world 40%
International
49%
world 18%
Olympia Diagnostics (United States)

Not ranked overall: Olympia Diagnostics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Olympia Diagnostics (United States) work in?

In all years, 35% of research at Olympia Diagnostics (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (35%), Biochemistry, Genetics and Molecular Biology (28%), Engineering (15%). It does 1.3× the world's share of Life Sciences.

Health Sciences: 2 fractional works · 35.2% of its workMedicine: 2 fractional works · 35.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 11.7% of its workOncology: 0 fractional works · 8.0% of its workEpidemiology: 0 fractional works · 6.6% of its workInfectious Diseases: 0 fractional works · 3.1% of its workOtorhinolaryngology: 0 fractional works · 2.0% of its workSurgery: 0 fractional works · 1.5% of its workPathology and Forensic Medicine: 0 fractional works · 1.3% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workLife Sciences: 2 fractional works · 34.5% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 28.1% of its workMolecular Biology: 1 fractional works · 19.2% of its workCancer Research: 0 fractional works · 8.0% of its workBiophysics: 0 fractional works · 0.9% of its workImmunology and Microbiology: 0 fractional works · 5.1% of its workMicrobiology: 0 fractional works · 3.1% of its workParasitology: 0 fractional works · 2.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.3% of its workPharmaceutical Science: 0 fractional works · 1.3% of its workPhysical Sciences: 2 fractional works · 29.2% of its workEngineering: 1 fractional works · 15.1% of its workElectrical and Electronic Engineering: 1 fractional works · 12.2% of its workBiomedical Engineering: 0 fractional works · 3.1% of its workChemistry: 0 fractional works · 8.0% of its workSpectroscopy: 0 fractional works · 7.1% of its workAnalytical Chemistry: 0 fractional works · 0.9% of its workPhysics and Astronomy: 0 fractional works · 6.0% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 6.0% of its workSocial Sciences: 0 fractional works · 1.1% of its workSocial Sciences: 0 fractional works · 1.1% of its workSociology and Political Science: 0 fractional works · 1.1% of its workALL ITS WORKOlympiaDiagnostics…5fractional works, all years
Life Sciences34%Physical Sciences29%Health Sciences35%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Medicine235.2%
    1. Biochemistry, Genetics and Molecular Biology228.1%
    2. Immunology and Microbiology05.1%
    3. Pharmacology, Toxicology and Pharmaceutics01.3%
    1. Engineering115.1%
    2. Chemistry08.0%
    3. Physics and Astronomy06.0%
    1. Social Sciences01.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Olympia Diagnostics (United States)?

The most cited paper from Olympia Diagnostics (United States) is "Non-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopy" (Rui Min Xiao, Xuhui Zhang, Zhen Rong et al., 2016), with 77 citations. Next come "Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test" (72) and "IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring" (48).

Most cited papers
#PaperReleasedCitations
1 Non-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopy Rui Min Xiao, Xuhui Zhang, Zhen Rong et al. · Nanomedicine Nanotechnology Biology and Medicine 10 Aug 2016 77
2 Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test Federico A. Monzon, Fabíola Medeiros, Maureen A. Lyons‐Weiler et al. · Diagnostic Pathology Open access 13 Jan 2010 72
3 IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring Yanfeng Zhao, Xiqin Yang, Xuhui Zhang et al. · Tuberculosis 19 May 2018 48
4 A novel and simple preparative method for uniform-sized PLGA microspheres: Preliminary application in antitubercular drug delivery Zhiqiang Liu, Xia Li, Bingshui Xiu et al. · Colloids and Surfaces B Biointerfaces 29 May 2016 33
5 Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up Heather K. Johnson, Jinan Guo, Xuhui Zhang et al. · BMC Medicine Open access Dec 2020 20
All 22 most cited papers, with filters and sorting

Which research topics does Olympia Diagnostics (United States) publish most on?

By volume in 2022-now: Colorectal Cancer Treatments and Studies, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies and Genetic factors in colorectal cancer.

Colorectal Cancer Treatm…0Colorectal Cancer Treatments and Studies: 0 fractional worksBreast Cancer Treatment …0Breast Cancer Treatment Studies: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksGenetic factors in color…0Genetic factors in colorectal cancer: 0 fractional worksSex work and related iss…0Sex work and related issues: 0 fractional worksToxoplasma gondii Resear…0Toxoplasma gondii Research Studies: 0 fractional worksParasitic Infections and…0Parasitic Infections and Diagnostics: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksHER2/EGFR in Cancer Rese…0HER2/EGFR in Cancer Research: 0 fractional works
OncologyCancer ResearchPulmonary and Respiratory MedicinePathology and Forensic Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Colorectal Cancer Treatments and Studies Oncology 0 works
  2. 2 Breast Cancer Treatment Studies Cancer Research 0 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  4. 4 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
  5. 5 Sex work and related issues Sociology and Political Science 0 works
  6. 6 Toxoplasma gondii Research Studies Parasitology 0 works
  7. 7 Parasitic Infections and Diagnostics Parasitology 0 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 0 works
  9. 9 HER2/EGFR in Cancer Research Oncology 0 works
  10. 10 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.6%not open67.4%

World: 40% of research is openly available.

with international co-authors48.8%domestic only51.2%

World: 18% is written across borders.

How has Olympia Diagnostics (United States)'s research output changed?

Output in 2022-2025 was 0% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Olympia Diagnostics (United States) as a percentage of every work published that year, 0.00000090% in 2024.

still counting0.000050%0.00010%Olympia Diagnostics (United States)0.0000029% in 202520102020

Fractional works of Olympia Diagnostics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Sunnyvale

All research institutions in Sunnyvale

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Olympia Diagnostics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.